These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30864705)

  • 1. Identification of exosomal and non‑exosomal microRNAs associated with the drug resistance of ovarian cancer.
    Feng Y; Hang W; Sang Z; Li S; Xu W; Miao Y; Xi X; Huang Q
    Mol Med Rep; 2019 May; 19(5):3376-3392. PubMed ID: 30864705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
    Kanlikilicer P; Bayraktar R; Denizli M; Rashed MH; Ivan C; Aslan B; Mitra R; Karagoz K; Bayraktar E; Zhang X; Rodriguez-Aguayo C; El-Arabey AA; Kahraman N; Baydogan S; Ozkayar O; Gatza ML; Ozpolat B; Calin GA; Sood AK; Lopez-Berestein G
    EBioMedicine; 2018 Dec; 38():100-112. PubMed ID: 30487062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT.
    Hang W; Feng Y; Sang Z; Yang Y; Zhu Y; Huang Q; Xi X
    Int J Mol Med; 2019 Jan; 43(1):256-266. PubMed ID: 30365097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.
    Zou J; Yin F; Wang Q; Zhang W; Li L
    Int J Clin Exp Pathol; 2015; 8(6):6847-58. PubMed ID: 26261572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7.
    Pan X; Shi X; Zhang H; Chen Y; Zhou J; Shen F; Wang J; Jiang R
    Gene; 2024 Nov; 927():148738. PubMed ID: 38955306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.
    Xin Y; Wang X; Meng K; Ni C; Lv Z; Guan D
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31763681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of upregulated exosomal miRNAs between A2780 and A2780/DDP human ovarian cancer cells by high-throughput sequencing.
    Wang H; Liu L; Liu Q; Zheng J; Zheng Q; Chen Y; Xia H; Wu Q; Sun Y
    J Ovarian Res; 2023 May; 16(1):94. PubMed ID: 37179363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of exosomal miRNAs derived from subcutaneous and visceral adipose tissues: Determination of targets for the treatment of obesity and associated metabolic disorders.
    Yang Z; Wei Z; Wu X; Yang H
    Mol Med Rep; 2018 Sep; 18(3):3314-3324. PubMed ID: 30066923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.
    Zhang S; Zhang X; Fu X; Li W; Xing S; Yang Y
    Oncol Lett; 2018 Aug; 16(2):2391-2401. PubMed ID: 30013629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
    Rashed MH; Kanlikilicer P; Rodriguez-Aguayo C; Pichler M; Bayraktar R; Bayraktar E; Ivan C; Filant J; Silva A; Aslan B; Denizli M; Mitra R; Ozpolat B; Calin GA; Sood AK; Abd-Ellah MF; Helal GK; Berestein GL
    Oncotarget; 2017 Mar; 8(12):20145-20164. PubMed ID: 28423620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study.
    Ruan L; Xie Y; Liu F; Chen X
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():31-38. PubMed ID: 29353130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
    Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
    Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal microRNA‑146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2‑mediated PI3K/Akt axis.
    Qiu L; Wang J; Chen M; Chen F; Tu W
    Int J Mol Med; 2020 Aug; 46(2):609-620. PubMed ID: 32626953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
    Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis.
    Zhao X; Ren Y; Cui N; Wang X; Cui Y
    Medicine (Baltimore); 2018 Sep; 97(39):e12632. PubMed ID: 30278585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance.
    Yang L; Li N; Wang H; Jia X; Wang X; Luo J
    Oncol Rep; 2012 Aug; 28(2):592-600. PubMed ID: 22614869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.